Financhill
Sell
36

JANX Quote, Financials, Valuation and Earnings

Last price:
$14.31
Seasonality move :
51.13%
Day range:
$13.82 - $14.16
52-week range:
$13.76 - $61.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
85.62x
P/B ratio:
0.87x
Volume:
1.4M
Avg. volume:
2.5M
1-year change:
-75.12%
Market cap:
$849.3M
Revenue:
$10.6M
EPS (TTM):
-$1.68

Earnings Data

Next earnings date for JANX
Feb 26
2026
Most recent earnings per share
-$0.39
Beat by $0.22
(Nov 6/2025)
Consensus Estimate
-$0.61
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $71.4K -- -- -$0.64 --
11/06/2025 Q3 $3.1M $10M -$0.39 -$0.61 $0.22
08/07/2025 Q2 $272.7K -- -$0.55 -$0.47 -$0.08
05/08/2025 Q1 $650K -- -$0.38 -$0.39 $0.01
12/31/2024 Q4 $1.3M -- -$0.36 -$0.45 $0.10
11/06/2024 Q3 $1.6M $439K -$0.51 -$0.36 -$0.16
08/07/2024 Q2 $863.1K $8.9M -$0.11 -$0.29 $0.18
05/08/2024 Q1 $1M $1.3M -$0.30 -$0.33 $0.03
03/08/2024 Q4 $739.3K $2.5M -$0.25 -$0.39 $0.14
11/07/2023 Q3 $845.5K $2.5M -$0.25 -$0.43 $0.18
08/08/2023 Q2 -- $1.1M -$0.42 -- --
05/09/2023 Q1 -- $2M -$0.42 -- --
03/10/2023 Q4 -- $2.8M -$0.39 -- --
11/10/2022 Q3 -- $1.8M -$0.40 -- --
08/09/2022 Q2 -- $2.4M -$0.41 -- --
05/10/2022 Q1 -- $1.6M -$0.32 -- --
03/18/2022 Q4 -- $1.6M -$0.33 -- --
11/09/2021 Q3 -- $1.2M -$0.26 -- --
08/10/2021 Q2 -- $482K -$0.15 -- --
03/31/2021 Q1 -- $380K -$0.05 -- --
12/31/2020 Q4 -- -- -$0.13 -- --
09/30/2020 Q3 -- -- -$0.03 -- --
06/30/2020 Q2 -- -- -$0.06 -- --
03/31/2020 Q1 -- -- -$0.03 -- --

Janux Therapeutics, Inc. Earnings Questions

  • How Much did Janux Therapeutics, Inc. Generate in Revenue Last Quarter?

    Janux Therapeutics, Inc. reported $10M worth of top line sales in its most recent quarter.

  • Did Janux Therapeutics, Inc. Beat Earnings Last Quarter?

    Janux Therapeutics, Inc. announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.61 per share.

  • Is Janux Therapeutics, Inc. Profitable?

    Janux Therapeutics, Inc. reported $9.5M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for Janux Therapeutics, Inc. EPS Next Year?

    Janux Therapeutics, Inc.'s earnings are forecast to decrease from -$1.28 per share to -$1.30 per share next year representing a decrease of -53.92%.

  • When is Janux Therapeutics, Inc.'s Earnings Date?

    Janux Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock